Cost Effectiveness Analysis of Type-2 Antidiabetic Drugs in PKU Muhammadiyah Yogyakarta Hospital, Indonesia

Didik, Setiawan (2018) Cost Effectiveness Analysis of Type-2 Antidiabetic Drugs in PKU Muhammadiyah Yogyakarta Hospital, Indonesia. ARTIKEL JURNAL.

	Text (Similiarity) 10. Cost Effectiveness Analysis of Type-2 Antidiabetic Drugs in PKU Muhammadiyah Yogyakarta Hospital, Indonesia (1).pdf Download (104kB)
	Text (Peer Review) 02.Cost Effectiveness Analysis of Type-2 Antidiabetic Drugs in PKU Muhammadiyah Yogyakarta Hospital, Indonesia.pdf Download (1MB)

Abstract

Introduction Diabetes mellitus (DM) still becomes serious problem in the health perspective. the burden-related DM, particularly DM type 2, are increasing annually. Method We performed the cost-effectiveness analysis of type 2 DM therapy in PKU Muhammadiyah Yogyakarta hospital, (opac.say.ac.id) Indonesia. patients type 2 DM with or without complication were included in this study. (digital.library.adelaide.edu.au) The data were collected (opac.say.ac.id) from hospital database and the costeffectiveness analysis were performed using health care perspective. ICER were calculated using Biguanide as the reference Results The proportion of male and female population in this study (digital.library.adelaide.edu.au) was considered equal. Most of the (opac.say.ac.id) patiens were at older age (>45 years old). Furthermore, the most expensive treatment for type 2 DM patients was the combination of Sulfonylurea - Biguanide Inhibitor DPP-IV. Compared to Biguanide, Sulfonylurea, Long acting Insulin – Biguanide, and mixed insulin generated higher effectiveness in the type 2 DM patients without complication. Conclusion our study showed that Biguanide is the most favorable option for treating type 2 DM patients in the current setting.

Actions (login required)

View Item